News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Balo Andrew K
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/14/2023 |
4
| Balo Andrew K (EVP Regulatory Strategy Clinic) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 3,275 shares
@ $111.399, valued at
$364.8k
Disposed/sold 2,405 shares
@ $111.399, valued at
$267.9k
Disposed/sold 5,990 shares
@ $111.399, valued at
$667.3k
|
|
| 03/10/2022 |
4
| Balo Andrew K (EVP, Global Medical Affairs) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 4,984 shares
@ $0.001, valued at
$5
Disposed/sold 932 shares
@ $406.0567, valued at
$378.4k
Disposed/sold 1,549 shares
@ $406.0567, valued at
$629k
Disposed/sold 949 shares
@ $406.0567, valued at
$385.3k
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 683 shares
@ $512.1872, valued at
$349.8k
Sold 200 shares
@ $512.8275, valued at
$102.6k
Sold 300 shares
@ $514.1771, valued at
$154.3k
Sold 300 shares
@ $515.3267, valued at
$154.6k
Sold 200 shares
@ $516.7225, valued at
$103.3k
Sold 200 shares
@ $518.0566, valued at
$103.6k
Sold 525 shares
@ $519.2352, valued at
$272.6k
Sold 349 shares
@ $519.9194, valued at
$181.5k
|
|
| 07/08/2021 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 578 shares
@ $428.5056, valued at
$247.7k
Sold 400 shares
@ $429.331, valued at
$171.7k
Sold 1,710 shares
@ $430.5576, valued at
$736.3k
Sold 286 shares
@ $432.0479, valued at
$123.6k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2020 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 5,256 shares
@ $397.3535, valued at
$2.1M
|
|
| 09/11/2020 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,283 shares
@ $398.302, valued at
$511k
Sold 3,297 shares
@ $398.302, valued at
$1.3M
|
|
| 06/17/2020 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 500 shares
@ $359.981, valued at
$180k
Sold 200 shares
@ $361.45, valued at
$72.3k
Sold 776 shares
@ $362.7174, valued at
$281.5k
Sold 205 shares
@ $363.4642, valued at
$74.5k
Sold 1,402 shares
@ $365.0301, valued at
$511.8k
Sold 400 shares
@ $366.6236, valued at
$146.6k
Sold 250 shares
@ $367.182, valued at
$91.8k
Sold 300 shares
@ $368.2917, valued at
$110.5k
Sold 2,239 shares
@ $370.0462, valued at
$828.5k
Sold 250 shares
@ $370.394, valued at
$92.6k
|
|
| 04/17/2020 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,032 shares
@ $279.3273, valued at
$288.3k
Sold 1,382 shares
@ $281.0976, valued at
$388.5k
Sold 1,110 shares
@ $284.1945, valued at
$315.5k
Sold 2,385 shares
@ $285.1425, valued at
$680.1k
Sold 730 shares
@ $286.2411, valued at
$209k
Sold 51 shares
@ $287.75, valued at
$14.7k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,386 shares
@ $151.46, valued at
$361.4k
|
|
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2019 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 37 shares
@ $170, valued at
$6.3k
|
|
| 06/06/2019 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 7,825 shares
@ $125, valued at
$978.1k
|
|
| 03/13/2019 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,222 shares
@ $142.7922, valued at
$317.3k
Sold 6,399 shares
@ $142.7922, valued at
$913.7k
Sold 2,296 shares
@ $142.7922, valued at
$327.9k
|
|
| 03/11/2019 |
4
| Balo Andrew K (*) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 14,987 shares
@ $0.001, valued at
$15 |
|
| 12/18/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 627 shares
@ $120.2302, valued at
$75.4k
Sold 4,373 shares
@ $121.3772, valued at
$530.8k
|
|
| 11/16/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,200 shares
@ $141.2508, valued at
$169.5k
Sold 800 shares
@ $142.13, valued at
$113.7k
Sold 1,502 shares
@ $143.8752, valued at
$216.1k
Sold 1,498 shares
@ $144.4316, valued at
$216.4k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 600 shares
@ $144.4618, valued at
$86.7k
Sold 4,400 shares
@ $145.2669, valued at
$639.2k
|
|
| 09/12/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,407 shares
@ $143.7552, valued at
$346k
Sold 3,180 shares
@ $143.7552, valued at
$457.1k
|
|
| 08/16/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 4,450 shares
@ $124.1631, valued at
$552.5k
Sold 550 shares
@ $124.9582, valued at
$68.7k
|
|
| 07/18/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,700 shares
@ $99.1215, valued at
$267.6k
Sold 1,800 shares
@ $99.9014, valued at
$179.8k
Sold 500 shares
@ $100.73, valued at
$50.4k
|
|
| 03/14/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 2,834 shares
@ $60.7306, valued at
$172.1k
Disposed/sold 2,221 shares
@ $60.7306, valued at
$134.9k
Disposed/sold 4,464 shares
@ $60.7306, valued at
$271.1k
|
|
| 03/12/2018 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 38,502 shares
@ $0.001, valued at
$38.5 |
|
| 12/13/2017 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 3,245 shares
@ $61.23, valued at
$198.7k
|
|
| 11/30/2017 |
4
| Balo Andrew K (EVP, Reg. Strategy, Clinical) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 6,490 shares
@ $60, valued at
$389.4k
|
|
| 09/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|